Inhibition of vascular epoprostenol (prostacyclin, PGI2) production in vitro by plasma from healthy subjects and patients with severe renal impairment.
Open Access
- 1 September 1982
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 14 (3) , 379-383
- https://doi.org/10.1111/j.1365-2125.1982.tb01994.x
Abstract
Click on the article title to read more.This publication has 20 references indexed in Scilit:
- Pathophysiological states modify levels in rat plasma of factors which inhibit synthesis and enhance breakdown of PGNature, 1980
- A plasma factor in uraemia which stimulates prostacyclin release from cultured endothelial cellsThrombosis Research, 1980
- Effect of serum on prostaglandin production during the co‐culture of human thyroid cells and peripheral blood mononuclear cellsJournal of Cellular Physiology, 1979
- A double blind placebo controlled crossover study of prostacyclin in manLife Sciences, 1979
- Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesisThrombosis Research, 1978
- Localisation and stimulation of prostacyclin production in vascular cellsNature, 1978
- Endogenous inhibitor of prostaglandin synthetaseNature, 1977
- PROSTACYCLIN AND ATHEROSCLEROSIS IN RATSThe Lancet, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Semiautomatic Coagulation Meter Utilizing Changes in ViscosityScandinavian Journal of Clinical and Laboratory Investigation, 1972